C Michael White

ORCID: 0000-0002-9367-4893
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Acute Ischemic Stroke Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Acute Myocardial Infarction Research
  • Medical Imaging and Pathology Studies
  • Cardiac electrophysiology and arrhythmias
  • Lipoproteins and Cardiovascular Health
  • Cardiac, Anesthesia and Surgical Outcomes
  • Peripheral Artery Disease Management
  • Cardiac Arrhythmias and Treatments
  • Case Reports on Hematomas
  • Blood Pressure and Hypertension Studies
  • Heart Failure Treatment and Management
  • Cardiac tumors and thrombi
  • Cardiac pacing and defibrillation studies
  • Diagnosis and treatment of tuberculosis
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • Pharmaceutical Economics and Policy
  • Soft tissue tumor case studies
  • Infective Endocarditis Diagnosis and Management
  • Pharmaceutical studies and practices

University of Connecticut
2016-2025

Hartford Hospital
2014-2024

Hartford Financial Services (United States)
2007-2024

William W Backus Hospital
2024

Royal Preston Hospital
2024

Westchester Medical Center
2023

University of Rochester Medical Center
2023

National Solar Observatory
2022

Hampshire Hospitals NHS Foundation Trust
2022

St. Luke's University Health Network
2022

Background— Many clinicians believe that statins cause muscle pain, but this has not been observed in clinical trials, and the effect of on performance carefully studied. Methods Results— The Effect Statins Skeletal Muscle Function Performance (STOMP) study assessed symptoms measured creatine kinase, exercise capacity, strength before after atorvastatin 80 mg or placebo was administered for 6 months to 420 healthy, statin-naive subjects. No individual kinase value exceeded 10 times normal,...

10.1161/circulationaha.112.136101 article EN Circulation 2012-11-27

Angiotensin II has been shown to increase hepatic glucose production and decrease insulin sensitivity. Patients who utilize either an ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB) may experience a decreased incidence of new-onset type 2 diabetes.Three reviewers conducted systematic literature search Medline, EMBASE, CINAHL, the Cochrane Library (1966 present) extract consensus trial data involving ACEI ARB with end point diabetes. Studies were included if they randomized...

10.2337/diacare.28.9.2261 article EN Diabetes Care 2005-09-01

Atrial fibrillation (AF) patients frequently require anticoagulation with vitamin K antagonists (VKAs) to prevent thromboembolic events, but their use increases the risk of hemorrhage. We evaluated time spent in therapeutic range (TTR), proportion international normalized ratio (INR) measurements (PINRR), adverse events relation INR, and predictors INR control AF using VKAs.We searched MEDLINE, CENTRAL EMBASE (1990-June 2013) for studies receiving adjusted-dose VKAs that reported measures...

10.1186/1477-9560-12-14 article EN cc-by Thrombosis Journal 2014-06-24

The effect of physical activity intensity on subjective well-being has not been well established. We examined this relationship among 419 healthy adults using objective and measurements (sample size varied assessments). For accelerometers, light-intensity positively associated with psychological ( n = 150) negatively depression 99); moderate pain severity 419) well-being; sedentary behavior ps < .05). These findings were generally consistent (Question 8, Paffenbarger Questionnaire)....

10.1177/1359105317691589 article EN Journal of Health Psychology 2017-02-12
Coming Soon ...